Skip to main content
Fig. 1 | Health and Quality of Life Outcomes

Fig. 1

From: Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol

Fig. 1

ePRO with the CHES software. Questionnaires are completed by patients using tablets and/or computer terminals via the CHES software (Computer-Based Health Evaluation System; https://ches.pro/index.php/ches) prior to each consultation at the oncology centre (waiting room) or at home via a secured portal. The physician will have real-time access to a visual summary of the HRQOL evaluation

Back to article page